Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

NCT06850727 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis (UC)
UC - Ulcerative Colitis

Interventions

DRUG: OD-07656
DRUG: Vedolizumab

Sponsor

Odyssey Therapeutics